Domov › Rak dojke › Minnesota › Rochester
Klinične študije za Rak dojke v Rochester, MN
42 študij za Rak dojke išče udeležence na lokacijah v Rochester in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
Vključevanje udeležencev
- Mayo Clinic in Rochester, Rochester
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
- Mayo Clinic in Rochester, Rochester
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Vključevanje udeležencevFaza 2
- Mayo Clinic, Rochester
PRE-ISPY Phase I/II Oncology Platform Program
Vključevanje udeležencevFaza 1/2
- Mayo Clinic Comprehensive Cancer Center, Rochester
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Vključevanje udeležencevFaza 2
- Mayo Clinic Cancer Center, Rochester
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Vključevanje udeležencev
- Mayo Clinic, Rochester
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Vključevanje udeležencev
- Mayo Clinic, Rochester
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Vključevanje udeležencevFaza 1
- Mayo Clinic - Rochester, Rochester
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Vključevanje udeležencevFaza 2
- Mayo Clinic in Rochester, Minnesota, Rochester
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Vključevanje udeležencevFaza 2
- Mayo Clinic, Rochester
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Vključevanje udeležencevFaza 1/2
- Mayo Rochester, Rochester
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Vključevanje udeležencevFaza 3
- Mayo Clinic, Rochester
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Vključevanje udeležencevFaza 1
- Mayo Clinic, Rochester
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Vključevanje udeležencevFaza 1/2
- Mayo Clinic, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Vključevanje udeležencevFaza 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
Vključevanje udeležencevFaza 1
- Mayo Clinic, Rochester
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- Mayo Clinic in Rochester, Rochester
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Mayo Clinic in Rochester, Rochester
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Vključevanje udeležencevFaza 3
- Mayo Clinic in Rochester, Rochester
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction
Vključevanje udeležencev
- Mayo Clinic in Rochester, Rochester
E-Mindfulness Approaches for Living After Breast Cancer
Vključevanje udeležencevFaza 3
- Mayo Clinic in Rochester, Rochester
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
Vključevanje udeležencevFaza 1
- Mayo Clinic in Rochester, Rochester
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Vključevanje udeležencevFaza 1
- Mayo Clinic Rochester, Rochester
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Vključevanje udeležencevFaza 1/2
- Mayo Clinic - Rochester, Rochester
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Vključevanje udeležencevFaza 3
- Mayo Clinic - Rochester, Rochester
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
Vključevanje udeležencevZgodnja faza 1
- Mayo Clinic in Rochester, Rochester
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
Vključevanje udeležencevFaza 1
- Mayo Clinic Rochester, Rochester
3D Ultrasound Breast Imaging
Vključevanje udeležencev
- Mayo Clinic in Rochester, Rochester
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Vključevanje udeležencev
- Mayo Clinic, Rochester
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Vključevanje udeležencevFaza 2
- Mayo Clinic, Rochester
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Vključevanje udeležencevFaza 3
- Mayo Clinic in Rochester, Rochester
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
Vključevanje udeležencevFaza 1/2
- Mayo Clinic, Rochester
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
Vključevanje udeležencevOpazovalna študija
- Mayo Clinic in Rochester, Rochester
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- Mayo Clinic, Rochester
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Vključevanje udeležencevOpazovalna študija
- Mayo Clinic, Rochester
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
Vključevanje udeležencevOpazovalna študija
- Mayo Clinic, Rochester
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
Vključevanje udeležencevOpazovalna študija
- Mayo Clinic in Rochester, Rochester
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
Vključevanje udeležencevOpazovalna študija
- Mayo Clinic in Rochester, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Mayo Clinic, Rochester
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Exelixis Clinical Site #14, Rochester
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
Vključevanje udeležencevFaza 1
- Biotheryx Investigative Site, Rochester
Študije za Rak dojke v drugih mestih
- New York City, NY136 študij
- Houston, TX126 študij
- Boston, MA112 študij
- Nashville, TN81 študij
- Los Angeles, CA73 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Queens, NY64 študij
- Durham, NC64 študij
- Chicago, IL59 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
Druge študije v Rochester
- Nemalicelični pljučni rak37 študij
- Metastatski rak31 študij
- Rak (vse vrste)30 študij
- Rak jajčnikov29 študij
- Kolorektalni rak29 študij
- Množni mielom24 študij
- Srčno popuščanje22 študij
- Rak prostate22 študij
- Rak trebušne slinavke22 študij
- Rak endometrija20 študij
- Rak pljuč20 študij
- Kronična limfocitna levkemija18 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.